Impact of a new diagnostic pathway for prostate cancer—from systematic transrectal to targeted MRI fusion transperineal biopsies
Transitioning to targeted transperineal biopsies improved cancer detection and reduced complications. While the Gleason score increased, risk groups and treatment plans remained unchanged. These results support implementation in clinical practice, though further studies are needed to assess long-term outcomes and broader applicability.
Authors
- Else Brohm Kallestrup
- Mads Hvid Poulsen (ORCID: https://orcid.org/0000-0002-7622-8402)
- Sara Vejlgaard Kristensen (ORCID: https://orcid.org/0009-0009-5692-7124)
- Martin Weiss Nielsen (ORCID: https://orcid.org/0000-0001-9047-5787)
- Katrine Thelle
Institutions
- University of Southern Denmark (DK)
- Region of Southern Denmark (DK)
- Hospital South West Jutland (DK)
Publication Details
- Journal
- International Urology and Nephrology
- Published
- 2025-11-03
- DOI
- https://doi.org/10.1007/s11255-025-04875-7
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00